000 | 01319 a2200385 4500 | ||
---|---|---|---|
005 | 20250511181338.0 | ||
264 | 0 | _c19921103 | |
008 | 199211s 0 0 eng d | ||
022 | _a0392-856X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRacadot, E | |
245 | 0 | 0 |
_aImmunological follow-up of 17 patients with rheumatoid arthritis treated in vivo with an anti-T CD4+ monoclonal antibody (B-F5) _h[electronic resource] |
260 |
_bClinical and experimental rheumatology _c |
||
300 |
_a365-74 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 |
_aArthritis, Rheumatoid _xblood |
650 | 0 | 4 |
_aC-Reactive Protein _xanalysis |
650 | 0 | 4 |
_aCD4 Antigens _xblood |
650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aCD8 Antigens _xblood |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-6 _xblood |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPilot Projects |
650 | 0 | 4 |
_aReceptors, Interleukin-2 _xanalysis |
650 | 0 | 4 |
_aT-Lymphocyte Subsets _ximmunology |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xanalysis |
700 | 1 | _aWijdenes, J | |
700 | 1 | _aWendling, D | |
773 | 0 |
_tClinical and experimental rheumatology _gvol. 10 _gno. 4 _gp. 365-74 |
|
999 |
_c1363180 _d1363180 |